Atrial fibrillation (Afib) is one of the most common sustained cardiac rhythm disorders, creating a growing burden on healthcare systems worldwide. Characterized by irregular and often rapid electrical activity in the upper chambers of the heart, the condition can increase the risk of stroke, heart failure, hospitalization, and other cardiovascular complications. As the prevalence of cardiovascular diseases rises and populations age, demand for effective diagnosis, monitoring, and treatment solutions continues to expand.